CH648206A5 - Compositions pharmaceutiques a liberation controlee de potassium. - Google Patents

Compositions pharmaceutiques a liberation controlee de potassium. Download PDF

Info

Publication number
CH648206A5
CH648206A5 CH9660/80A CH966080A CH648206A5 CH 648206 A5 CH648206 A5 CH 648206A5 CH 9660/80 A CH9660/80 A CH 9660/80A CH 966080 A CH966080 A CH 966080A CH 648206 A5 CH648206 A5 CH 648206A5
Authority
CH
Switzerland
Prior art keywords
potassium
microcapsules
salt
weight
surfactant
Prior art date
Application number
CH9660/80A
Other languages
English (en)
French (fr)
Inventor
Irwin Lippmann
Shankar Dass Popli
Larry Gene Miller
Louis Gary Bell
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22572135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH648206(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of CH648206A5 publication Critical patent/CH648206A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH9660/80A 1980-06-13 1980-12-31 Compositions pharmaceutiques a liberation controlee de potassium. CH648206A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/159,335 US4259315A (en) 1980-06-13 1980-06-13 Controlled release potassium dosage form

Publications (1)

Publication Number Publication Date
CH648206A5 true CH648206A5 (fr) 1985-03-15

Family

ID=22572135

Family Applications (1)

Application Number Title Priority Date Filing Date
CH9660/80A CH648206A5 (fr) 1980-06-13 1980-12-31 Compositions pharmaceutiques a liberation controlee de potassium.

Country Status (13)

Country Link
US (1) US4259315A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5714525A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU544965B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE886973A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1135624A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH648206A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3100808A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2484254A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2077587B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL61817A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1212512B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL192430C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH15605A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
AU571312B2 (en) * 1984-02-10 1988-04-14 Nycomed Danmark A/S Diffusion coated multiple-units dosage form
WO1986003121A1 (en) * 1984-11-27 1986-06-05 Sawruk Stephen D Tissue re-calcification product
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
ES8801121A1 (es) * 1985-02-19 1988-01-01 Key Pharma Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5932252A (en) * 1988-10-21 1999-08-03 The Regents Of The University Of California Method and composition for treatment of osteoporosis
US5498428A (en) * 1988-10-21 1996-03-12 The Regents Of The University Of California Treatment of hypertension by oral administration of potassium bicarbonate
HU201869B (en) * 1988-12-30 1991-01-28 Egyt Gyogyszervegyeszeti Gyar Process for producing microcapsules of quick dissolving active component
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
US5895662A (en) * 1997-12-31 1999-04-20 Meyer; Martha C. Meat product pet medicine capsule
ATE213935T1 (de) 1998-04-09 2002-03-15 Eurand Int Benetzbare mikrokapseln, die mit ethylcellulose überzogene kerne besitzen
US6506401B1 (en) 1999-01-28 2003-01-14 H. J. Heinz Company Filled edible product, and system and method for production of a filled edible product
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
DE10011447A1 (de) * 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
ES2287126T3 (es) 2000-04-27 2007-12-16 Verion Inc. Microcapsulas de liberacion de orden cero y controladas por la temperatura y procedimiento para su preparacion.
AU2001275043A1 (en) 2000-05-31 2001-12-11 Drugtech Corporation Mineral supplement
JP4689114B2 (ja) * 2000-11-02 2011-05-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビタミンと加工大蒜を含有するカプセル剤
US6780437B2 (en) * 2001-10-23 2004-08-24 Upsher-Smith Laboratories, Inc. Coated potassium chloride granules and tablets
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
JPWO2009041111A1 (ja) * 2007-09-28 2011-01-20 リンテック株式会社 経口投与剤
WO2012134441A1 (en) * 2011-03-29 2012-10-04 Empire Technology Development Llc Microcapsule corrosion control in reinforced concrete
DE102017201095A1 (de) * 2017-01-24 2018-07-26 Henkel Ag & Co. Kgaa Tenside in Kapseln mit optimiertem Trübungspunkt

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415758A (en) * 1960-03-09 1968-12-10 Ncr Co Process of forming minute capsules en masse
DE2224256C2 (de) * 1972-05-18 1985-05-23 Sanol-Arzneimittel Dr. Schwarz Gmbh, 4019 Monheim Arzneimittelzubereitung
JPS5112919A (en) * 1974-07-19 1976-01-31 Smith Kline French Lab Johoseisoseibutsuno seiho
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet

Also Published As

Publication number Publication date
DE3100808A1 (de) 1982-01-07
PH15605A (en) 1983-02-28
JPS5714525A (en) 1982-01-25
NL192430B (nl) 1997-04-01
GB2077587A (en) 1981-12-23
AU544965B2 (en) 1985-06-27
NL8100468A (nl) 1982-01-04
IT1212512B (it) 1989-11-22
BE886973A (fr) 1981-05-04
GB2077587B (en) 1983-10-12
CA1135624A (en) 1982-11-16
AU6589880A (en) 1981-12-24
IL61817A0 (en) 1981-01-30
FR2484254A1 (fr) 1981-12-18
US4259315A (en) 1981-03-31
IT8167071A0 (it) 1981-01-22
DE3100808C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-07-26
NL192430C (nl) 1997-08-04
JPH0260649B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-12-17
FR2484254B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-06-10
IL61817A (en) 1983-11-30

Similar Documents

Publication Publication Date Title
CH648206A5 (fr) Compositions pharmaceutiques a liberation controlee de potassium.
EP1003488B1 (fr) Procede de preparation de nanocapsules de type vesiculaire
BE1015217A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP1524969A2 (fr) Microcapsules a liberation modifiee de principes actifs peu solubles pour administration per os
CH667008A5 (fr) Procede pour le traitement de formes de dosage pharmaceutiques.
EP1524968A2 (fr) Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
EP1333816A2 (fr) Medicament a base de microcapsules d'anti-hyperglycemiant a liberation prolongee et son procede de preparation
CA2452239C (fr) Formulation pharmaceutique au gout masque et son procede de preparation
FR2527438A1 (fr) Microcapsules a paroi constituee par des polyholosides reticules et leur procede de preparation
EP0300897A2 (fr) Dispositif à libération contrôlée qui fournit une délivrance continue d'un principe actif de manière contrôlée et compositions à particules multiples contenant de tels dispostifs
JP2000510488A (ja) 改良投薬ユニット
EP1368002B1 (fr) Procede de fabrication d'un comprime flottant incluant de l'alfuzosine
CN118236506A (zh) 一种提高口服生物利用度的基于植物甾醇油酸酯的脂质体
FR2540727A1 (fr) Nouvelle preparation retard contenant de la n''-cyano-n-4-pyridyl-n'-1,2,2-trimethylpropylguanidine, utile notamment dans le traitement de l'hypertension
EP0966270A1 (en) Novel method for obtaining microspheres and resulting products
FR2934780A1 (fr) Composition pharmaceutique sous forme de granules et procede de fabrication d'une telle composition pharmaceutique.
JPH10502358A (ja) 作用物質の遊離遅延を伴うカルバマゼピン薬剤
JP2000514100A (ja) 可溶化されたセルトラリン組成物
EP0036345B1 (fr) Nouveau procédé d'enrobage d'au moins un principe actif médicamenteux, les nouveaux médicaments ainsi obtenus, et les compositions les renfermant
BE839625A (fr) Procede pour l'enrobage enterique de medicaments ainsi enrobes
CH650150A5 (fr) Composition pharmaceutique renfermant du cromoglycate de sodium.
FR2769853A1 (fr) Nouveau procede d'obtention de microspheres et les produits ainsi realises
CN1256984C (zh) 胰岛素固体粒子及其制备方法和该固体粒子在制备治疗糖尿病药物中的应用
CA2598410A1 (fr) Forme pharmaceutique orale de losartan
CA2022447A1 (fr) Forme galenique orale ameliorant la biodisponibilite

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: A. H. ROBINS COMPANY, INCORPORATED (A DELAWARE COR

PUE Assignment

Owner name: AHP SUBSIDIARY (9) CORPORATION

PFA Name/firm changed

Owner name: A. H. ROBINS COMPANY, INCORPORATED (A DELAWARE COR